Phase I study of tenofovir alafenamide and its metabolite tenofovir in HIV–uninfected subjects with severe renal impairment versus matched-control subjects with normal renal function.
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir
- Indications HIV infections; Renal impairment
- Focus Pharmacokinetics
- 07 Jun 2016 New trial record
- 23 May 2016 Results published in the Antimicrobial Agents and Chemotherapy